Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn’s Disease during One-Year Follow-Up

Background: Seven weeks of high-dose vitamin D treatment decreases intestinal IL17A and IFN-γ mRNA expression in active Crohn’s disease (CD). In this follow-up study, we investigated whether seven-week vitamin D treatment affected the infliximab response in the following 45 weeks compared to placebo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bendix, Mia, Dige, Anders, Jørgensen, Søren Peter, Dahlerup, Jens Frederik, Bibby, Bo Martin, Deleuran, Bent, Agnholt, Jørgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065492/
https://www.ncbi.nlm.nih.gov/pubmed/33810258
http://dx.doi.org/10.3390/nu13041083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065492/
https://www.ncbi.nlm.nih.gov/pubmed/33810258
http://dx.doi.org/10.3390/nu13041083

Ejemplares similares